Pancreatic Cancer Research

ResearcherFlinders UniversityActive in the last 2 years

Savio George Barreto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4999-5657; OpenAlex author ID A5031393949. Sources: OpenAlex.

Their work

Papers
32 (first author 4, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
42
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: 2 papers · 2020: 4 papers · 2021: 5 papers · 2022: 3 papers · 2023: 2 papers · 2024: 5 papers · 2025: none · 2026: 5 papers

Papers 32

  1. Pancreatic Cancer-Advances in the Last 50 Years. Co-author DOI 10.1002/wjs.70309↗
  2. Absolute risk of pancreatic cancer in people with acute pancreatitis - theAustralian experience. Last author DOI 10.1016/j.hpb.2026.05.011↗
  3. International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580↗
  4. Surgery for Locally Advanced Pancreatic Ductal Adenocarcinoma: Selection of Patients and Surgical Technique. Co-author DOI 10.1159/000550333↗
  5. The sensitivity of decision support tools for identifying patients with pancreatic cancer: an observational study. Co-author DOI 10.3399/bjgpo.2025.0142↗
  6. Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer. Co-author DOI 10.1007/s13193-021-01361-1↗
  7. REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives. Co-author DOI 10.1007/s13304-024-01860-0↗
  8. Can we "prehabilitate" pancreatic cancer patients prior to surgery? A critical appraisal of the literature. Co-author DOI 10.1016/j.clnesp.2024.08.003↗
  9. The burden of young-onset pancreatic cancer and its risk factors from 1990 to 2019: A systematic analysis of the global burden of disease study 2019. Last author DOI 10.1016/j.pan.2023.12.005↗
  10. REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006248↗
  11. Extended distal pancreatectomy in pancreatic cancer: is it justified? A systematic review of literature. Last author DOI 10.2217/fon-2022-1180↗
  12. Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities. Co-author DOI 10.3390/cancers15082354↗
  13. Enhancing the cost-effectiveness of surgical care in pancreatic cancer: a systematic review and cost meta-analysis with trial sequential analysis. Last author DOI 10.1016/j.hpb.2021.11.004↗
  14. The influence of socioeconomic status on access to cancer care and survival in resectable pancreatic cancer: a systematic review and meta-analysis. Last author DOI 10.1111/ans.17964↗
  15. Interview with Prof. Savio George Barreto: pancreatic cancer-an old problem needs a fresh perspective. Co-author DOI 10.21037/cco-22-71↗
  16. Synchronous arterial resections in pancreatic cancer - still a matter of debate? Co-author DOI 10.1016/j.ejso.2020.06.028↗
  17. Pancreatic ductal adenocarcinoma survival in South Australia: time trends and impact of tumour location. Last author DOI 10.1111/ans.16767↗
  18. Is enhancing recovery after pancreatic cancer surgery even possible?-a narrative review. First author DOI 10.21037/cco-21-36↗
  19. Birth of a solid organ cancer-the cell fusion hypothesis presented with pancreatic cancer as a model: a narrative review. Co-author DOI 10.21037/cco-21-69↗
  20. Surgery for pancreatic cancer: current controversies and challenges. First author DOI 10.2217/fon-2021-0533↗
  21. Islets and pancreatic ductal adenocarcinoma - An opportunity for translational research from the 'Bench to the Bedside'. Co-author DOI 10.1016/j.pan.2020.02.001↗
  22. Pancreatic cancer in the Australian population: identifying opportunities for intervention. Co-author DOI 10.1111/ans.16272↗
  23. Does biology determine survival in pancreatic cancer? Co-author DOI 10.2217/fon-2019-0706↗
  24. Pancreatic cancer in Australia: is not it time we address the inequitable resource problem? Co-author DOI 10.2217/fon-2020-0109↗
  25. Is it time to reconsider the principles of pancreatic cancer surgery? Co-author DOI 10.1016/j.pan.2018.12.003↗
  26. Detecting tumour response and predicting resectability after neoadjuvant therapy for borderline resectable and locally advanced pancreatic cancer. Co-author DOI 10.1111/ans.14764↗
  27. Pancreatic cancer: let us focus on cachexia, not just sarcopenia! Co-author DOI 10.2217/fon-2018-0369↗
  28. Does revision of resection margins based on frozen section improve overall survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma? A met… Co-author DOI 10.1016/j.hpb.2017.03.006↗
  29. The concept of 'borderline resectable' pancreatic cancer: limited foundations and limited future? First author DOI 10.21037/jgo.2016.12.06↗
  30. Vitamin D and pancreatic cancer. Co-author DOI 10.1016/j.canlet.2015.06.030↗
  31. Tumour size and lymph node metastases as prognostic markers of pancreatic cancer: old lessons revisited. Co-author PMID 24758447↗
  32. Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature. First author DOI 10.1111/j.1477-2574.2012.00508.x↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Monish Karunakaran · 6 shared papers, 2021–2024 · strength 1.37
  2. John Albert Windsor · 5 shared papers, 2017–2026 · strength 0.98
  3. Sanjay Pandanaboyana · 3 shared papers, 2017–2026 · strength 0.62
  4. Rachel Ε. Neale · 3 shared papers, 2015–2026 · strength 0.58
  5. Bhawna Sirohi · 2 shared papers, 2019–2024 · strength 0.56
  6. Benjamin P. T. Loveday · 2 shared papers, 2019–2026 · strength 0.52
  7. Daniel Gerald Croagh · 2 shared papers, 2026 · strength 0.48
  8. Katina D’Onise · 2 shared papers, 2020–2021 · strength 0.43
  9. Shailesh Vinayak Shrikhande · 2 shared papers, 2012–2024 · strength 0.41
  10. Sagar H. Chandrashekhar · 2 shared papers, 2022–2023 · strength 0.40
  11. Anubhav Mittal · 1 shared paper, 2026 · strength 0.39
  12. Richard Zheng · 1 shared paper, 2026 · strength 0.36
  13. Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.36
  14. Anirban Maitra · 1 shared paper, 2026 · strength 0.36
  15. Dushyant V. Sahani · 1 shared paper, 2026 · strength 0.36
  16. Charles J. Yeo · 1 shared paper, 2026 · strength 0.36
  17. Simranjeet Singh Dahia · 1 shared paper, 2024 · strength 0.31
  18. Stephen Jacob Pandol · 1 shared paper, 2024 · strength 0.31
  19. Jorg H. Kleeff · 1 shared paper, 2021 · strength 0.28
  20. Richard C. Turner · 1 shared paper, 2026 · strength 0.26
  21. Minoti Vivek Apte · 1 shared paper, 2026 · strength 0.26
  22. Tony Pang · 1 shared paper, 2026 · strength 0.26
  23. Mark E. Brooke‐Smith · 1 shared paper, 2026 · strength 0.26
  24. Lucas Wigston · 1 shared paper, 2026 · strength 0.26
  25. Lucine M. Gao · 1 shared paper, 2022 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.